Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00378482
Status:
COMPLETED
Last Update Posted:
2023-11-14
First Post:
2006-09-19
Brief Title:
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-19
First Submit QC Date:
September 19 2006
Study First Post Date:
2006-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-05-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-21
Last Update Post Date:
2023-11-14
Last Update Post Date Type:
ACTUAL